Please login to the form below
molnupiravir
This page shows the latest molnupiravir news and features for those working in and with pharma, biotech and healthcare.
Merck & Co halts development of potential COVID-19 drug MK-7110
Merck is now focusing its efforts on advancing molnupiravir, which, as an oral medicine for outpatient use, represents a promising potential new approach, and on accelerating production of Johnson &Johnson’s ... According to the early data, presented
Latest news
-
Merck & Co, Ridgeback Biotherapeutics’ COVID-19 drug shows early promise
Molnupiravir led to a faster decrease in infectious virus among participants with early COVID-19. ... Molnupiravir is being evaluated in phase 2/3 clinical trials in hospital and outpatients settings, with a primary completion date set for May 2021.
-
Merck & Co to help produce J&J’s COVID-19 vaccine in the US
The second treatment, MK-4482 or molnupiravir, is an investigational oral antiviral candidate that Merck &Co is developing with Ridgeback Bio.
-
Merck ends its COVID-19 vaccine programme after disappointing early trial results
The second treatment, MK-4482 or molnupiravir, is an investigational oral antiviral candidate that Merck is developing with Ridgeback Bio.
Merck & Co, Ridgeback Biotherapeutics’ COVID-19 drug shows early promise
Merck & Co to help produce J&J’s COVID-19 vaccine in the US
More from news
Approximately 1 fully matching, plus 3 partially matching documents found.
COVID-19 Updates and Daily News
Featured jobs
- Client Services Director – London or Home Based – Medical Commun...
-
Highly Competitive Salary, Bonus &Benefits
-
Senior Medical Writer
-
Competitive Salary
- Editor & Senior Editor - Medical Communications - Home Based
-
Highly Competitive Salary, Bonus &Benefits
- Senior Medical Writer– Medical Education – Oxford - London
-
Excellent Remuneration Package
- Home Working Medical Copy Writer & Senior Medical Copy Write...
-
Highly Competitive Salary, Bonus &Benefits
- Senior Account Manager/ Account Director
-
Competitive Salary Offered
- Medical Writers (All levels) Editorial / Scientific Leads & ...
-
Highly Competitive Remuneration packages
-
Associate Account Director
-
Competitive Salary
-
Publications Director
-
Competitive Salary
-
Senior Account Executive
-
Competitive Salary
- Medical Writer, Senior Medical Writer, Principal Medical Writer,...
-
Highly Competitive Salary, Bonus &Benefits
- Head of Strategic Planning, Healthcare Advertising/ Brand comms,...
-
Six figure salary
- Account Manager / Senior Account Manager - Creative MedComms - C...
-
Excellent Remuneration
-
Account Manager
-
Competitive Salary
-
Medical Editor
-
Competitive Salary
- Account Manager - Creative Healthcare Communications - South Wes...
-
Excellent Remuneration
- Senior & Principal Medical Writer
-
Competitive Salary Offered
- Senior Account / Programme Manager - MedComms - Buckinghamshire
-
Highly Competitive Remuneration packages
- Group Account Director, Healthcare Advertising/ Brand comms, Lon...
-
8 month contract up to £90K
-
Account Management
-
Competitive Salary Offered
- Senior Account Director & Associate Director - Healthcare Ad...
-
Highly Competitive Salary, Bonus &Benefits
- Merck & Co reveals plans for women’s health spinoff Organon
- bluebird bio aiming to separate business units by year-end
- Novavax is close to finalising a COVID-19 vaccine supply deal with the EU
- EMA launches rolling review of GSK/Vir Biotech’s mAb for early COVID-19
- AbbVie lauds head-to-head win for Skyrizi versus Cosentyx
- AZ, Amgen file first-in-class asthma drug with the FDA
- Developers of COVID-19 vaccines and therapeutics highlight continued need for treatments
- Pfizer asks UK's MHRA to approve its COVID-19 vaccine in adolescents
- Clark Health promotes Siân Hurst to managing director role
- ENGINE MHP+Mischief bolsters healthcare comms expertise with new senior hires
- New court filing alleges Sanofi destroyed emails relating to Zantac recall
- Pfizer warns that IP waiver for COVID-19 vaccines may invite ‘copycat medicines’
- Pfizer asks UK's MHRA to approve its COVID-19 vaccine in adolescents
- New court filing alleges Sanofi destroyed emails relating to Zantac recall
- Merck & Co reveals plans for women’s health spinoff Organon
- Virtual agency The Difference Collective makes new hires to senior team
- Sourcing R&D innovation: why pharma companies need to evolve their business models
- The impact of cancer on mental health during COVID-19
PMHub
Anthill Agency
Digital communications agency empowering clients through their digital transformation journey. Whether through training, delivering solutions or devising digital strategies, we...
Latest intelligence
- How innovating study sites can improve patient recruitment efficiency
- There are so many ways that clinical trials have innovated over the last few years. There is now a larger focus on making trials more patient-centric, more virtualised, and more...
- Avoiding A Series of Unfortunate Events: launch lessons from lockdown
- Chris Ross takes a novel look at launch excellence through the lens of COVID-19 and explores how pharma’s launch leaders are rewriting the story...
- 6 reasons patients drop out of clinical trials and 6 ways to fix it
- If you’ve successfully recruited patients for your clinical trial, but one by one, they begin to drop out, then this information could be for you....
